Copyright Reports & Markets. All rights reserved.

Global Lornoxicam Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Lornoxicam Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 4mg
    • 1.3.3 8mg
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Lornoxicam Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital and Clinic
    • 1.4.3 Pharmacy
  • 1.5 Global Lornoxicam Tablets Market Size & Forecast
    • 1.5.1 Global Lornoxicam Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Lornoxicam Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Lornoxicam Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Takeda Pharmaceuticals
    • 2.1.1 Takeda Pharmaceuticals Details
    • 2.1.2 Takeda Pharmaceuticals Major Business
    • 2.1.3 Takeda Pharmaceuticals Lornoxicam Tablets Product and Services
    • 2.1.4 Takeda Pharmaceuticals Lornoxicam Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Takeda Pharmaceuticals Recent Developments/Updates
  • 2.2 Lupin Limited
    • 2.2.1 Lupin Limited Details
    • 2.2.2 Lupin Limited Major Business
    • 2.2.3 Lupin Limited Lornoxicam Tablets Product and Services
    • 2.2.4 Lupin Limited Lornoxicam Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Lupin Limited Recent Developments/Updates
  • 2.3 Glenmark
    • 2.3.1 Glenmark Details
    • 2.3.2 Glenmark Major Business
    • 2.3.3 Glenmark Lornoxicam Tablets Product and Services
    • 2.3.4 Glenmark Lornoxicam Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Glenmark Recent Developments/Updates
  • 2.4 Zhejiang Zhenyuan Pharmaceutical
    • 2.4.1 Zhejiang Zhenyuan Pharmaceutical Details
    • 2.4.2 Zhejiang Zhenyuan Pharmaceutical Major Business
    • 2.4.3 Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Product and Services
    • 2.4.4 Zhejiang Zhenyuan Pharmaceutical Lornoxicam Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Zhejiang Zhenyuan Pharmaceutical Recent Developments/Updates
  • 2.5 Shandong Jincheng Pharmaceutical
    • 2.5.1 Shandong Jincheng Pharmaceutical Details
    • 2.5.2 Shandong Jincheng Pharmaceutical Major Business
    • 2.5.3 Shandong Jincheng Pharmaceutical Lornoxicam Tablets Product and Services
    • 2.5.4 Shandong Jincheng Pharmaceutical Lornoxicam Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Shandong Jincheng Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Lornoxicam Tablets by Manufacturer

  • 3.1 Global Lornoxicam Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Lornoxicam Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Lornoxicam Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Lornoxicam Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Lornoxicam Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Lornoxicam Tablets Manufacturer Market Share in 2025
  • 3.5 Lornoxicam Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Lornoxicam Tablets Market: Region Footprint
    • 3.5.2 Lornoxicam Tablets Market: Company Product Type Footprint
    • 3.5.3 Lornoxicam Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Lornoxicam Tablets Market Size by Region
    • 4.1.1 Global Lornoxicam Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Lornoxicam Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Lornoxicam Tablets Average Price by Region (2021-2032)
  • 4.2 North America Lornoxicam Tablets Consumption Value (2021-2032)
  • 4.3 Europe Lornoxicam Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Lornoxicam Tablets Consumption Value (2021-2032)
  • 4.5 South America Lornoxicam Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Lornoxicam Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Lornoxicam Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Lornoxicam Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Lornoxicam Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Lornoxicam Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Lornoxicam Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Lornoxicam Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Lornoxicam Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Lornoxicam Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Lornoxicam Tablets Market Size by Country
    • 7.3.1 North America Lornoxicam Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Lornoxicam Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Lornoxicam Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Lornoxicam Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Lornoxicam Tablets Market Size by Country
    • 8.3.1 Europe Lornoxicam Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Lornoxicam Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Lornoxicam Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Lornoxicam Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Lornoxicam Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Lornoxicam Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Lornoxicam Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Lornoxicam Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Lornoxicam Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Lornoxicam Tablets Market Size by Country
    • 10.3.1 South America Lornoxicam Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Lornoxicam Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Lornoxicam Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Lornoxicam Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Lornoxicam Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Lornoxicam Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Lornoxicam Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Lornoxicam Tablets Market Drivers
  • 12.2 Lornoxicam Tablets Market Restraints
  • 12.3 Lornoxicam Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Lornoxicam Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Lornoxicam Tablets
  • 13.3 Lornoxicam Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Lornoxicam Tablets Typical Distributors
  • 14.3 Lornoxicam Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Lornoxicam Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Lornoxicam is a non-steroidal anti-inflammatory (NSAID) medicine used for temporary relief of swelling, stiffness, and pain associated with Rheumatoid Arthritis, Osteoarthritis, Spondylitis etc.
    This report is a detailed and comprehensive analysis for global Lornoxicam Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Lornoxicam Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Lornoxicam Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Lornoxicam Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Lornoxicam Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Lornoxicam Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Lornoxicam Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceuticals, Lupin Limited, Glenmark, Zhejiang Zhenyuan Pharmaceutical, Shandong Jincheng Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Lornoxicam Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    4mg
    8mg
    Market segment by Application
    Hospital and Clinic
    Pharmacy
    Major players covered
    Takeda Pharmaceuticals
    Lupin Limited
    Glenmark
    Zhejiang Zhenyuan Pharmaceutical
    Shandong Jincheng Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Lornoxicam Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Lornoxicam Tablets, with price, sales quantity, revenue, and global market share of Lornoxicam Tablets from 2021 to 2026.
    Chapter 3, the Lornoxicam Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Lornoxicam Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Lornoxicam Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Lornoxicam Tablets.
    Chapter 14 and 15, to describe Lornoxicam Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now